Mark Holliday

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Ejection Fraction

Patient Reported

Top Venues

ERJ open research

The European respiratory journal

This page only lists publications with an associated author ORCID identifier.

Publications

Juliet M Foster, Richard Beasley, Irene Braithwaite, Timothy Harrison, Mark Holliday, Ian Douglas Pavord, Helen K Reddel
Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study. BMJ open 12 (1) (2022)
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ open research 7 (1) (2021)
Christina Baggott, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Daniela Hall, Alexandra Vohlidkova, Robert J Hancox, Mark Weatherall, James Fingleton, Richard Beasley, null null
Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial. The European respiratory journal 56 (4) (2020)
Christina Baggott, Paul Hansen, Robert J Hancox, Jo Katherine Hardy, Jenny Sparks, Mark Holliday, Mark Weatherall, Richard Beasley, Helen K Reddel, James Fingleton, null null
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experiment. Thorax 75 (10) (2020)